| Literature DB >> 28660284 |
Jamsheer Jehangir Talati1, Sally-Anne Hulton2, Sander F Garrelfs3, Wajahat Aziz4, Shoaib Rao4, Amanullah Memon4, Zafar Nazir4, Raziuddin Biyabani4, Saqib Qazi4, Iqbal Azam5, Aysha Habib Khan6, Jamil Ahmed4, Lena Jafri6, Mohammad Zeeshan7.
Abstract
Primary hyperoxalurias (PH) are devastating, autosomal recessive diseases causing renal stones. Undifferentiated hyperoxaluria is seen in up to 43% of Pakistani paediatric stone patients. High rates of consanguinity in Pakistan suggest significant local prevalence. There is no detailed information regarding number of cases, clinical features, and genetics in Pakistan-origin (P-o) patients. We reviewed available information on P-o PH patients recorded in the literature as well as from two major PH registries (the Rare Kidney Stone Consortium PH Registry (RKSCPHR) and the OxalEurope PH Registry (OxER); and the Aga Khan University Hospital in Pakistan. After excluding overlaps, we noted 217 P-o PH subjects (42 in OxER and 4 in RKSCPHR). Presentations were protean. Details of mutations were available for 94 patients of 201 who had genetic analyses. Unique mutations were noted. Mutation [c.508G>A (p. Gly170Arg)] (present in up to 25% in the West) was reported in only one case. In one series, only 30% had mutations on exons 1,4,7 of AGXT. Of 42 P-o patients in OxER, 52.4% were PH1, 45.2% PH2, and 2.4% PH3. Of concern is that diagnosis was made after renal transplant rejection (four cases) and on bone-marrow aspiration (in five). Lack of consideration of PH as a diagnosis, late diagnosis, and loss of transplanted kidneys mandates that PH be searched for diligently. Mutation analysis will need to extend to all exons and include PH 1,2,3. There is a need to spread awareness and identify patients through a scoring or screening system that alerts physicians to consider a diagnosis of PH.Entities:
Keywords: Consanguinity; End-stage renal disease; Mutation analysis; Oxalate crystals; Oxalate stones; Oxalosis; Pakistan origin; Primary hyperoxaluria
Mesh:
Substances:
Year: 2017 PMID: 28660284 DOI: 10.1007/s00240-017-0996-8
Source DB: PubMed Journal: Urolithiasis ISSN: 2194-7228 Impact factor: 3.436